Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Senard

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1994
N-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphanJ L Montastruc, N Fabre, O Rascol, et al.
Revue Neurologique|November 1, 1994
[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance]M E Llau, L Nguyen, J M Senard, et al.
Advances in Neurology|January 1, 1993
Vestibulo-ocular reflex in Parkinson's disease and multiple system atrophyO J Rascol, M Clanet, J M Senard, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|February 24, 2001
Lack of autonomic nervous dysfunction in progressive supranuclear palsy, a study of blood pressure variabilityC Brefel-Courbon, C Thalamas, O Rascol, et al.
British Journal of Pharmacology|October 1, 1990
Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dogL Estan, J M Senard, M A Tran, et al.
Therapie|September 1, 1994
[Drug-induced Parkinson syndrome: 10 years of drug vigilance]M E Llau, L Nguyen, J M Senard, et al.
Fundamental & Clinical Pharmacology|January 1, 1997
Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotensionP Verwaerde, M A Tran, J L Montastruc, et al.
Lancet (London, England)|June 17, 1999
Water drinking and the heartJ M Senard, C Brefel, C Carel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1997
A dose-ranging study of selegiline in patients with Parkinson's disease: effect of platelet monoamine oxidase activityN Andreu, C Damase-Michel, J M Senard, et al.
Clinical Neuropharmacology|February 1, 1991
Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsoniansG Durrieu, J M Senard, M A Tran, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1994
N-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphanJ L Montastruc, N Fabre, O Rascol, et al.
Revue Neurologique|November 1, 1994
[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance]M E Llau, L Nguyen, J M Senard, et al.
Advances in Neurology|January 1, 1993
Vestibulo-ocular reflex in Parkinson's disease and multiple system atrophyO J Rascol, M Clanet, J M Senard, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|February 24, 2001
Lack of autonomic nervous dysfunction in progressive supranuclear palsy, a study of blood pressure variabilityC Brefel-Courbon, C Thalamas, O Rascol, et al.
British Journal of Pharmacology|October 1, 1990
Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dogL Estan, J M Senard, M A Tran, et al.
Therapie|September 1, 1994
[Drug-induced Parkinson syndrome: 10 years of drug vigilance]M E Llau, L Nguyen, J M Senard, et al.
Fundamental & Clinical Pharmacology|January 1, 1997
Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotensionP Verwaerde, M A Tran, J L Montastruc, et al.
Lancet (London, England)|June 17, 1999
Water drinking and the heartJ M Senard, C Brefel, C Carel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1997
A dose-ranging study of selegiline in patients with Parkinson's disease: effect of platelet monoamine oxidase activityN Andreu, C Damase-Michel, J M Senard, et al.
Clinical Neuropharmacology|February 1, 1991
Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsoniansG Durrieu, J M Senard, M A Tran, et al.
Pageof 13